This is wild to me that the price has stagnated. We've basically derisked and having a working blood test for ovarian cancer as well as other cancers in the pipeline.. We are this close to commercialisation. I'd imagine if nothing else with our IP we'd make a fantastic take over target. It's a matter of time before BD1 stock price is re-rated to multiple x our current market cap.. My guess is that by early next year these prices will be a memory. We're so far ahead of other biotechs in that we actually have a working product, now it's just a waiting game until the money starts flowing in. Well done BD1 team
DYOR and have fun
This is wild to me that the price has stagnated. We've basically...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
-0.010(1.75%) |
Mkt cap ! $59.09M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 54.0¢ | $96.73K | 176.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | 55.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.0¢ | 7999 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |